State Street
ETON icon

State Street’s Eton Pharmaceutcials ETON Stock Holding History

State Street’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.4M Buy
701,786
+171,571
+32% +$5.03M ﹤0.01% 2232
2026
Q1 		$13.1M Buy
530,215
+28,290
+6% +$495K ﹤0.01% 2465
2025
Q4 		$8.49M Buy
501,925
+63,480
+14% +$1.12M ﹤0.01% 2726
2025
Q3 		$9.53M Buy
438,445
+115,251
+36% +$1.91M ﹤0.01% 2664
2025
Q2 		$4.61M Buy
323,194
+208,958
+183% +$3.3M ﹤0.01% 2981
2025
Q1 		$1.48M Buy
114,236
+8,900
+8% +$134K ﹤0.01% 3341
2024
Q4 		$1.4M Buy
105,336
+23,933
+29% +$243K ﹤0.01% 3414
2024
Q3 		$488K Hold
81,403
– – ﹤0.01% 3601
2024
Q2 		$268K Hold
81,403
– – ﹤0.01% 3734
2024
Q1 		$305K Hold
81,403
– – ﹤0.01% 3771
2023
Q4 		$357K Hold
81,403
– – ﹤0.01% 3724
2023
Q3 		$339K Buy
81,403
+10,400
+15% +$40.1K ﹤0.01% 3771
2023
Q2 		$248K Hold
71,003
– – ﹤0.01% 3933
2023
Q1 		$273K Hold
71,003
– – ﹤0.01% 3958
2022
Q4 		$199K Hold
71,003
– – ﹤0.01% 4100
2022
Q3 		$149K Sell
71,003
-6,900
-9% -$17.2K ﹤0.01% 4263
2022
Q2 		$204K Sell
77,903
-13,700
-15% -$46K ﹤0.01% 4185
2022
Q1 		$399K Buy
91,603
+7,831
+9% +$30.8K ﹤0.01% 4135
2021
Q4 		$359K Hold
83,772
– – ﹤0.01% 4123
2021
Q3 		$422K Hold
83,772
– – ﹤0.01% 4043
2021
Q2 		$516K Sell
83,772
-182,523
-69% -$1.35M ﹤0.01% 3839
2021
Q1 		$1.95M Buy
266,295
+21,900
+9% +$187K ﹤0.01% 3448
2020
Q4 		$1.99M Buy
244,395
+66,519
+37% +$513K ﹤0.01% 3383
2020
Q3 		$1.41M Buy
177,876
+26,980
+18% +$184K ﹤0.01% 3337
2020
Q2 		$822K Buy
+150,896
New +$749K ﹤0.01% 3457

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

State Street's ETON Position: Q2 2026 in Review

State Street increased its Eton Pharmaceutcials (ETON) stake by 32% in Q2 2026, buying an estimated $5.03M and bringing the position to 701,786 shares worth $25.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

State Street first reported a position in ETON in Q2 2020 and has held it in 25 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • State Street held 701,786 shares of Eton Pharmaceutcials worth $25.4M as of Q2 2026.
  • State Street bought 171,571 Eton Pharmaceutcials shares in Q2 2026, an estimated $5.03M.
  • Eton Pharmaceutcials made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2232 holding.
  • State Street first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 25 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.